163 related articles for article (PubMed ID: 35537276)
1. Is there a link between neuropathic pain and constipation in NMOSD and MOGAD? Results from an online patient survey and possible clinical implications.
Lotan I; Romanow G; Levy M; Kister I
Mult Scler Relat Disord; 2022 Jul; 63():103825. PubMed ID: 35537276
[TBL] [Abstract][Full Text] [Related]
2. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.
Nagireddy RBR; Kumar A; Singh VK; Prasad R; Pathak A; Chaurasia RN; Mishra VN; Joshi D
J Neuroimmunol; 2021 Dec; 361():577742. PubMed ID: 34655992
[TBL] [Abstract][Full Text] [Related]
3. Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.
Rempe T; Tarhan B; Rodriguez E; Viswanathan VT; Gyang TV; Carlson A; Tuna IS; Rees J
Mult Scler Relat Disord; 2021 Feb; 48():102718. PubMed ID: 33388560
[TBL] [Abstract][Full Text] [Related]
4. Seizures and epilepsy in multiple sclerosis, aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease.
Li EC; Zheng Y; Cai MT; Lai QL; Fang GL; Du BQ; Shen CH; Zhang YX; Wu LJ; Ding MP
Epilepsia; 2022 Sep; 63(9):2173-2191. PubMed ID: 35652436
[TBL] [Abstract][Full Text] [Related]
5. Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder.
Camera V; Holm-Mercer L; Ali AAH; Messina S; Horvat T; Kuker W; Leite MI; Palace J
JAMA Netw Open; 2021 Dec; 4(12):e2137833. PubMed ID: 34878547
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of clinical and imaging data between patients with myelin oligodendrocyte glycoprotein antibody disease and patients with aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder.
Xie H; Shao Y; Du J; Song Y; Li Y; Duan R; Yao Y; Gong Z; Teng J; Jia Y
J Neurol; 2022 Mar; 269(3):1641-1650. PubMed ID: 34383114
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of AQP4-NMOSD, MOGAD and seronegative NMOSD: a single-center Belgian cohort.
Dauby S; Dive D; Lutteri L; Andris C; Hansen I; Maquet P; Lommers E
Acta Neurol Belg; 2022 Feb; 122(1):135-144. PubMed ID: 34097296
[TBL] [Abstract][Full Text] [Related]
8. Myelitis in inflammatory disorders associated with myelin oligodendrocyte glycoprotein antibody and aquaporin-4 antibody: A comparative study in Chinese Han patients.
ZhangBao J; Huang W; Zhou L; Wang L; Chang X; Lu C; Zhao C; Lu J; Quan C
Eur J Neurol; 2021 Apr; 28(4):1308-1315. PubMed ID: 33220172
[TBL] [Abstract][Full Text] [Related]
9. Serum Neurofilament Light and GFAP Are Associated With Disease Severity in Inflammatory Disorders With Aquaporin-4 or Myelin Oligodendrocyte Glycoprotein Antibodies.
Chang X; Huang W; Wang L; ZhangBao J; Zhou L; Lu C; Wang M; Yu J; Li H; Li Y; Zhao C; Lu J; Quan C
Front Immunol; 2021; 12():647618. PubMed ID: 33796113
[No Abstract] [Full Text] [Related]
10. Brighter spotty lesions on spinal MRI help differentiate AQP4 antibody-positive NMOSD from MOGAD.
Hyun JW; Lee HL; Park J; Kim J; Min JH; Kim BJ; Kim SW; Shin HY; Huh SY; Kim W; Seo JW; Kim KH; Kim SH; Kim HJ
Mult Scler; 2022 May; 28(6):989-992. PubMed ID: 34865555
[TBL] [Abstract][Full Text] [Related]
11. Comparison of neutrophil-to-lymphocyte ratio between myelin oligodendrocyte glycoprotein antibody-associated disease and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders in adults.
Duan Z; Feng J
J Clin Neurosci; 2022 Jul; 101():89-93. PubMed ID: 35569419
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the safety profile of COVID-19 vaccines in patients with MS, NMOSD, and MOGAD.
Kim S; Seok HY
Neurol Sci; 2023 Jun; 44(6):1841-1848. PubMed ID: 36781562
[TBL] [Abstract][Full Text] [Related]
13. Distinct features of B cell receptors in neuromyelitis optica spectrum disorder among CNS inflammatory demyelinating diseases.
Kim HJ; Park JE; Shin W; Seo D; Kim S; Kim H; Noh J; Lee Y; Kim H; Lim YM; Kim H; Lee EJ
J Neuroinflammation; 2023 Oct; 20(1):225. PubMed ID: 37794409
[TBL] [Abstract][Full Text] [Related]
14. Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood-brain barrier breakdown and peripheral plasmablasts.
Tanaka S; Hashimoto B; Izaki S; Oji S; Fukaura H; Nomura K
Mult Scler Relat Disord; 2020 Jun; 41():102005. PubMed ID: 32114369
[TBL] [Abstract][Full Text] [Related]
15. The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?
Sen S; Tuncer A; Ozakbas S; Uzunkopru C; Baba C; Demir S; Beckmann Y; Gumus H; Arslan G; Kilic AK; Altintas A; Yuceyar N; Turan OF; Tutuncu M; Terzi M; Acar P; Bunul SD; Balci BP; Bir LS; Koseoglu M; Mungan S; Gunduz T; Dogan IG; Kotan D; Uygunoglu U; Ekmekci O; Demirkiran M; Kamisli O; Kabay SC; Tamam Y; Omerhoca S; Sevim S; Guler S; Kurtuncu M; Efendi H; Karabudak R; Siva A
Mult Scler Relat Disord; 2022 Feb; 58():103399. PubMed ID: 35216782
[TBL] [Abstract][Full Text] [Related]
16. Chiasmatic lesions on conventional magnetic resonance imaging during the first event of optic neuritis in patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease in a Latin American cohort.
Carnero Contentti E; López PA; Criniti J; Pettinicchi JP; Cristiano E; Patrucco L; Bribiesca Contreras E; Gómez-Figueroa E; Flores-Rivera J; Correa-Díaz EP; Toral Granda AM; Ortiz Yepez MA; Gualotuña Pachacama WA; Piedra Andrade JS; Galleguillos L; Tkachuk V; Nadur D; Daccach Marques V; Soto de Castillo I; Casas M; Cohen L; Alonso R; Caride A; Lana-Peixoto M; Rojas JI
Eur J Neurol; 2022 Mar; 29(3):802-809. PubMed ID: 34799965
[TBL] [Abstract][Full Text] [Related]
17. Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: current topics.
Fujihara K; Cook LJ
Curr Opin Neurol; 2020 Jun; 33(3):300-308. PubMed ID: 32374571
[TBL] [Abstract][Full Text] [Related]
18. A systematic literature review to examine the considerations around pregnancy in women of child-bearing age with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) or aquaporin 4 neuromyelitis optica spectrum disorder (AQP4+ NMOSD).
Leite MI; Panahloo Z; Harrison N; Palace J
Mult Scler Relat Disord; 2023 Jul; 75():104760. PubMed ID: 37224631
[TBL] [Abstract][Full Text] [Related]
19. A study of referral bias in NMOSD and MOGAD cohorts.
Leal Rato M; Chen B; Francis A; Messina S; Miron M; Sharawakanda Y; O'Sullivan E; Cooper S; Fisniku L; Halfpenny C; Martin R; Hobart J; Rashid W; Hemingway C; Williams V; Hacohen Y; Dobson R; Ramdas S; Leite MI; Palace J; Geraldes R
Mult Scler Relat Disord; 2024 May; 85():105553. PubMed ID: 38552551
[TBL] [Abstract][Full Text] [Related]
20. Dysphagia in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody disease as a surrogate of brain involvement?
Pawlitzki M; Ahring S; Rolfes L; Dziewas R; Warnecke T; Suntrup-Krueger S; Wiendl H; Klotz L; Meuth SG; Labeit B
Eur J Neurol; 2021 May; 28(5):1765-1770. PubMed ID: 33338309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
